TRXB · TRex Bio, Inc. · Documents
$16.16
+1.72 (+11.91%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$396.32M
Shares
27.45M
Volume · Oct 21
53.77K
Avg daily vol (8 sessions)
290.28K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Following its IPO consummation on October 13, 2026, TRex Bio, Inc. authorized 225 million common shares and 25 million undesignated preferred shares, eliminated prior preferred-stock series and stockholder action by written consent. | 2026-10-13 | — | |
| S-1/A | — | 2026-10-05 | — | |
| S-1 | — | 2026-09-18 | — |
Showing 1–3 of 3 filings